Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.65 |
| ▸ | VNN1 | O95497 | 13/20 | 0.59 |
| ▸ | ECE1 | P42892 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantothenic Acid SCHEMBL27903324 | 1.00 | PTGS1 (0.65) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL8506535 | 1.00 | PTGS1 (0.65) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid, Racemic SCHEMBL5437 | 0.98 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL5436 | 0.98 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL29872649 | 0.98 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL21547 | 0.98 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL7016631 | 0.98 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL14126322 | 0.98 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid, Racemic SCHEMBL21114380 | 0.98 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL8428189 | 0.97 | PTGS1 (0.61) | PTGS1KCNH2VNN1ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074579-A | Ginseng adventitious root pressed candy and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260034171-A1 | Composition for Improving Cognitive Function | PERRY STEPHEN C (US) | 2026-02-05 | — | — | US | claimed |
| US-12509706-B2 | Methods for preparing pantoic acid, pantothenic acid and panthenol as well as salts thereof | MINT BIOTECHNOLOGIES CO., LTD. (CN) | 2025-12-30 | — | — | US | claimed |
| CN-119769630-A | Traditional Chinese medicine anti-coccidiosis ruminant compound feed | 大庆市天赐饲料有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119454701-A | Ophthalmic preparation containing cevimeline and preparation method and application thereof | 苏州普乐康医药科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118401238-A | Topical composition for acne and topical composition for selective antibacterial/bactericidal treatment of propionibacterium acnes | 狮王株式会社 | 2024-07-26 | — | — | CN | claimed |
| CN-117120412-A | Production of panthenol | 帝斯曼知识产权资产管理有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-113846127-B | Preparation method of pantoic acid, pantothenic acid and panthenol and salts thereof | 元素驱动(杭州)生物科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-116999389-A | Vitamin B6 injection containing sodium pantothenate and preparation method thereof | 西藏邦臣药业集团有限公司 | 2023-11-07 | — | — | CN | claimed |
| US-20230348941-A1 | METHODS FOR PREPARING PANTOIC ACID, PANTOTHENIC ACID AND PANTHENOL AS WELL AS SALTS THEREOF | MINT BIOTECHNOLOGIES CO., LTD. (CN) | 2023-11-02 | — | — | US | claimed |
| US-6096125-A | Ink compositions | XEROX CORPORATION (US) | 2000-08-01 | — | — | US | claimed |
| EP-0673434-B1 | DEVICE FOR CARRYING OUT UREASE TESTS FOR COMBINED ANTRUM/CORPUS BIOPSIES TO DIAGNOSE GASTRO-INTESTINAL ILLNESSES | ASTRA AB (SE) | 1999-07-28 | — | — | EP | claimed |
| EP-0759750-A4 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1998-05-27 | — | — | EP | claimed |
| US-5750107-A | PLANT EXTRACTS | NOMURA MANABU (JP) | 1998-05-12 | — | — | US | claimed |
| US-5709737-A | AQUEOUS LIQUID VEHICLE, COLORANT, ALCOHOL ADDITIVE; SUITABLE FOR MICROWAVE DRYING PROCESSES | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | claimed |
| CN-1151288-A | Nutrient for prevention and treatment of fatty liver caused by drinking wine and fat and its mfg. method | YAN HUAIWEI (CN) | 1997-06-11 | — | — | CN | claimed |
| EP-0759750-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO, Howard, K. (US) | 1997-03-05 | — | — | EP | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | claimed |
| US-4717663-A | XANTHOMONAS, CULTURES, AEROBIC, PANTOTHENIC ACID AND/OR THIAMINE (DERIVATIVE) | THE NISSHIN OIL MILLS, LTD. (JP) | 1988-01-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034171-A1 | Composition for Improving Cognitive Function | PHOSPHO1, PSEN1, S100B | PTGS1 1922/4885KCNH2 2677/4885VNN1 3011/4885 |
| US-12509706-B2 | Methods for preparing pantoic acid, pantothenic acid and panthenol as well as salts thereof | AKR7A2, COASY, ALAD | PTGS1 1335/4885KCNH2 2787/4885VNN1 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.